PL
PL · PL · PL-100433701
Verpyllo
ATC R06AX29
Last synced from URPL (Poland) on
Identification
ManufacturerSTADA Arzneimittel AG
CountryPL (PL)
ATC codeR06AX29
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 6
- gtin05909991468767
- gtin05909991468774
- gtin05909991468781
- gtin05909991468798
- gtin05909991468804
- gtin05909991468811
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909991468767 ¦ Rp ¦ Skasowane ¦ 142355\n30 tabl.\n05909991468774 ¦ OTC ¦ 142356\n10 tabl.\n05909991468781 ¦ Rp ¦ Skasowane ¦ 142357\n50 tabl.\n05909991468798 ¦ Rp ¦ Skasowane ¦ 142358\n20 tabl.\n05909991468804 ¦ Rp ¦ Skasowane ¦ 142359\n100 tabl.\n05909991468811 ¦ Rp ¦ Skasowane ¦ 142360\n40 tabl.",
"substance": "Bilastinum monohydricum 20.776 mg",
"common_name": "Bilastinum",
"pl_product_id": "100433701",
"pozwolenie_nr": "26923",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}Related drugs
Other records sharing ATC code R06AX29.
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CZABISAXGlenmark Pharmaceuticals s.r.o., Praha
Access this data programmatically
Query Verpyllo and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.